Oxidative modification of proteins: An emerging mechanism of cell signaling

Frontiers in Physiology

Volumn 3 SEP, Issue , 2012, Pages

  Wall, Stephanie B ^a   Oh, Joo Yeun ^a   Diers, Anne R ^b   Landar, Aimee ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

15 deoxy prostaglandin J 2 (15d PGJ 2); Electrophile; Reactive species; Redox signaling; Thiol

Indexed keywords

EID: 84867169460     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00369     Document Type: Article

References (95)

1. Alp, N. J., and Channon, K. M. (2004). Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler. Thromb. Vasc. Biol. 24, 413-420.
2. Barouch, L. A., Harrison, R. W., Skaf, M. W., Rosas, G. O., Cappola, T. P., Kobeissi, Z. A., Hobai, I. A., Lemmon, C. A., Burnett, A. L., O'Rourke, B., Rodriguez, E. R., Huang, P. L., Lima, J. A., Berkowitz, D. E., and Hare, J. M. (2002). Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416, 337-339.
3. Beckmann, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., and White, C. R. (1994). Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler 375, 81-88.
4. Berndt, C., Lillig, C. H., and Holmgren, A. (2007). Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: implications for diseases in the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol. 292, H1227-H1236.
5. Brennan, P., and O'Neill, L. A. (1998). Inhibition of nuclear factor kappaB by direct modification in whole cells - mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem. Pharmacol. 55, 965-973.
6. Brigelius-Flohe, R.,and Flohe, L. (2011). Basic principles and emerging concepts in the redox control of transcription factors. Antioxid. Redox Signal. 15, 2335-2381.
7. Brookes, P. S., Levonen, A. L., Shiva, S., Sarti, P., and Darley-Usmar, V. M. (2002). Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 33, 755-764.
8. Brown, G. C., and Borutaite, V. (2002). Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic. Biol. Med. 33, 1440-1450.
9. Bryk, R., Griffin, P., and Nathan, C. (2000). Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407, 211-215.
10. Carr, A. C., van den Berg, J. J., and Winterbourn, C. C. (1998). Differential reactivities of hypochlorous and hypobromous acids with purified Escherichia coli phospholipid: formation of haloamines and halohydrins. Biochim. Biophys. Acta 1392, 254-264.
11. Catala, A. (2009). Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem. Phys. Lipids 157, 1-11.
12. Chae, H. Z., Uhm, T. B., and Rhee, S. G. (1994). Dimerization of thiol-specific antioxidant and the essential role of cysteine 47. Proc. Natl. Acad. Sci. U.S.A. 91, 7022-7026.
13. Chang, T. S., Jeong, W., Woo, H. A., Lee, S. M., Park, S., and Rhee, S. G.(2004).Characterizationof mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J. Biol. Chem. 279, 50994-51001.
14. Chen, K., Craige, S. E., and Keaney, J. F. Jr. (2009). Downstream targets and intracellular compartmentalization in Nox signaling. Antioxid. Redox Signal. 11, 2467-2480.
15. Clarke, J. D., Dashwood, R. H., and Ho, E. (2008). Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 269, 291-304.
16. D'Autreaux, B., and Toledano, M. B. (2007). ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8, 813-824.
17. Diers, A. R., Dranka, B. P., Ricart, K. C., Oh, J. Y., Johnson, M. S., Zhou, F., Pallero, M. A., Bodenstine, T. M., Murphy-Ullrich, J. E., Welch, D. R., and Landar, A. (2010a). Modulation of mammary cancer cell migration by 15-deoxydelta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy. Biochem. J. 430, 69-78.
18. Diers, A. R., Higdon, A. N., Ricart, K. C., Johnson, M. S., Agarwal, A., Kalyanaraman, B., Landar, A., and DarleyUsmar, V. M. (2010b). Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms. Biochem. J. 426, 31-41.
19. Dinkova-Kostova, A. T., Holtzclaw, W. D., and Kensler, T. W. (2005). The role of Keap1 in cellular protective responses. Chem. Res. Toxicol. 18, 1779-1791.
20. Fabiato, A. (1983). Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am. J. Physiol. 245, C1-C14.
21. Finkel, T. (2011). Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7-15.
22. Forman, H. J., Fukuto, J. M., and Torres, M. (2004). Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am. J. Physiol., Cell Physiol. 287, C246- C256.
23. Frand, A. R., Cuozzo, J. W., and Kaiser, C. A. (2000). Pathways for protein disulphide bond formation. Trends Cell Biol. 10, 203-210.
24. Gayarre, J., Stamatakis, K., Renedo, M., and Perez-Sala, D. (2005). Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione. FEBS Lett. 579, 5803-5808.
25. Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., and Willoughby, D. A. (1999). Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5, 698-701.
26. Go, Y. M., Duong, D. M., Peng, J., and Jones, D. P. (2011). Protein cysteines map to functional networks according to steady-state level of oxidation. J. Proteomics Bioinform. 4, 196-209.
27. Gonzalez, D. R., Treuer, A., Sun, Q. A., Stamler, J. S., and Hare, J. M. (2009). S-Nitrosylation of cardiac ion channels. J. Cardiovasc. Pharmacol. 54, 188-195.
28. Gruetter, C. A., Barry, B. K., McNamara, D. B., Gruetter, D. Y., Kadowitz, P. J., and Ignarro, L. (1979). Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J. Cyclic Nucleotide Res. 5, 211-224.
29. Higdon, A., Diers, A. R., Oh, J. Y., Landar, A., and Darley-Usmar, V. M. (2012). Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem. J. 442, 453-464.
30. Hill, B. G., Dranka, B. P., Bailey, S. M., Lancaster, J. R. Jr., and DarleyUsmar, V. M. (2010). What part of NO don't you understand? Some answers to the cardinal questions in nitric oxide biology. J. Biol. Chem. 285, 19699-19704.
31. Hill, B. G., Reily, C., Oh, J. Y., Johnson, M. S., and Landar, A. (2009). Methods for the determination and quantification of the reactive thiol proteome. Free Radic. Biol. Med. 47, 675-683.
32. Hong, F., Freeman, M. L., and Liebler, D. C. (2005). Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem. Res. Toxicol. 18, 1917-1926.
33. Hurst, J. K., and Barrette, W. C. Jr. (1989). Leukocytic oxygen activation and microbicidal oxidative toxins. Crit. Rev. Biochem. Mol. Biol. 24, 271-328.
34. Itoh, K., Mochizuki, M., Ishii, Y., Ishii, T., Shibata, T., Kawamoto, Y., Kelly, V., Sekizawa, K., Uchida, K., and Yamamoto, M. (2004). Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-Delta(12,14)prostaglandin j(2). Mol. Cell. Biol. 24, 36-45.
35. Jacob, C., Giles, G. I., Giles, N. M., and Sies, H. (2003). Sulfur and selenium: the role of oxidation state in protein structure and function. Angew. Chem. Int. Ed. Engl. 42, 4742-4758.
36. Jin, S., Zhou, F., Katirai, F., and Li, P. L. (2011). Lipid raft redox signaling: molecular mechanisms in health and disease. Antioxid. Redox Signal. 15, 1043-1083.
37. Jones, D. P. (2010). Redox sensing: orthogonal control in cell cycle and apoptosis signalling. J. Intern. Med. 268, 432-448.
38. Jones, D. P., and Go, Y. M. (2010). Redox compartmentalization and cellular stress. Diabetes Obes. Metab. 12(Suppl 2), 116-125.
39. Jones, D. P., Go, Y. M., Anderson, C. L., Ziegler, T. R., Kinkade, J. M. Jr., and Kirlin, W. G. (2004). Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J. 18, 1246-1248.
40. Kadl, A., Bochkov, V. N., Huber, J., and Leitinger, N. (2004). Apoptotic cells as sources for biologically active oxidized phospholipids. Antioxid. Redox Signal. 6, 311-320.
41. Karg, K., Dirsch, V. M., Vollmar, A. M., Cracowski, J. L., Laporte, F., and Mueller, M. J. (2007). Biologically active oxidized lipids (phytoprostanes) in the plant diet and parenteral lipid nutrition. Free Radic. Res. 41, 25-37.
42. Kaspar, J. W., Niture, S. K., and Jaiswal, A. K. (2009). Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 47, 1304-1309.
43. Klomsiri, C., Karplus, P. A., and Poole, L. B. (2011). Cysteine-based redox switches in enzymes. Antioxid. Redox Signal. 14, 1065-1077.
44. Kobayashi, A., Kang, M. I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., and Yamamoto, M. (2004). Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130-7139.
45. Kobayashi, A., Kang, M. I., Watai, Y., Tong, K. I., Shibata, T., Uchida, K., and Yamamoto, M. (2006). Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 26, 221-229.
46. Landar, A., Zmijewski, J. W., Dickinson, D. A., Le Goffe, C., Johnson, M. S., Milne, G. L., Zanoni, G., Vidari, G., Morrow, J. D., and Darley-Usmar, V. M. (2006). Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am. J. Physiol. Heart Circ. Physiol. 290, H1777-H1787.
47. Levonen, A. L., Landar, A., Ramachandran, A., Ceaser, E. K., Dickinson, D. A., Zanoni, G., Morrow, J. D., and Darley-Usmar, V. M. (2004). Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 378, 373-382.
48. LoPachin, R. M., and Barber, D. S. (2006). Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants. Toxicol. Sci. 94, 240-255.
49. LoPachin, R. M., and Decaprio, A. P. (2005). Protein adduct formation as a molecular mechanism in neurotoxicity. Toxicol. Sci. 86, 214-225.
50. LoPachin, R. M., Gavin, T., Geohagen, B. C., and Das, S. (2007). Neurotoxic mechanisms of electrophilic type-2 alkenes: soft soft interactions described by quantum mechanical parameters.Toxicol. Sci. 98,561-570.
51. Lopez-Lazaro, M. (2008). Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent. Mol. Nutr. Food Res. 52(Suppl 1), S103-S127.
52. Martindale, J. L., and Holbrook, N. J. (2002). Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192, 1-15.
53. Martinez-Moreno, M., AlvarezBarrientos, A., Roncal, F., Albar, J. P., Gavilanes, F., Lamas, S., and Rodriguez-Crespo, I. (2005). Direct interaction between the reductase domain of endothelial nitri coxide synthase and the ryanodine receptor. FEBS Lett. 579, 3159-3163.
54. Martyniuk, C. J., Fang, B., Koomen, J. M., Gavin, T., Zhang, L., Barber, D. S., and Lopachin, R. M. (2011). Molecular mechanism of glyceraldehyde3-phosphate dehydrogenase inactivation by alpha, beta-unsaturated carbonyl derivatives. Chem. Res.Toxicol. 24, 2302-2311.
55. McMahon, M., Itoh, K., Yamamoto, M., and Hayes, J. D. (2003). Keap1dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response elementdriven gene expression. J. Biol. Chem. 278, 21592-21600.
56. Oh, J. Y., Giles, N., Landar, A., and Darley-Usmar, V. (2008). Accumulation of 15-deoxy-delta(12,14)prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. Biochem. J. 411, 297-306.
57. Pacher, P., Beckman, J. S., and Liaudet, L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424.
58. Paulsen, C. E., and Carroll, K. S. (2010). Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem. Biol. 5, 47-62.
59. Peluffo, G., and Radi, R. (2007). Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc. Res. 75, 291-302.
60. Pignatelli, M., Sanchez-Rodriguez, J., Santos, A., and Perez-Castillo, A. (2005). 15-deoxy-Delta-12, 14-prostaglandin J2 induces programmed cell death of breast cancer cells by a pleiotropic mechanism. Carcinogenesis 26, 81-92.
61. Poole, L. B., Karplus, P. A., and Claiborne, A. (2004). Protein sulfenic acids in redox signaling. Annu. Rev. Pharmacol. Toxicol. 44, 325-347.
62. Renedo, M., Gayarre, J., GarciaDominguez, C. A., Perez-Rodriguez, A., Prieto, A., Canada, F. J., Rojas, J. M., and Perez-Sala, D. (2007). Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. Biochemistry 46, 6607-6616.
63. Rhee, S. G., Chae, H. Z., and Kim, K. (2005). Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38, 1543-1552.
64. Rhee, S. G., Chang, T. S., Bae, Y. S., Lee, S. R., and Kang, S. W. (2003). Cellular regulation by hydrogen peroxide. J. Am. Soc. Nephrol. 14, S211-S215.
65. Rhee, S. G., Kang, S. W., Netto, L. E., Seo, M. S., and Stadtman, E. R. (1999). A family of novel peroxidases, peroxiredoxins. Biofactors 10, 207-209.
66. Rhee, S. G., Woo, H.A., Kil, I. S.,and Bae, S. H. (2012). Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J. Biol. Chem. 287, 4403-4410.
67. Ricart, K. C., Bolisetty, S., Johnson, M. S., Perez, J., Agarwal, A., Murphy, M. P., and Landar, A. (2009). The permissive role of mitochondria in the induction of haem oxygenase-1 in endothelial cells. Biochem. J. 419, 427-436.
68. Rudolph, T. K., and Freeman, B. A. (2009). Transduction of redox signaling by electrophile-protein reactions. Sci. Signal. 2, re7.
69. Sakiniene, E., Bremell, T., and Tarkowski, A. (1997). Inhibition of nitric oxide synthase (NOS) aggravates Staphylococcus aureus septicaemia and septic arthritis. Clin. Exp. Immunol. 110, 370-377.
70. Schmidt, P., Youhnovski, N., Daiber, A., Balan, A., Arsic, M., Bachschmid, M., Przybylski, M., and Ullrich, V. (2003). Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J. Biol. Chem. 278, 12813-12819.
71. Shacter, E. (2000). Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev. 32, 307-326.
72. Sies, H. (1993). Strategies of antioxidant defense. Eur. J. Biochem. 215, 213-219.
73. Spencer, J. P., Kuhnle, G. G., Williams, R. J., and Rice-Evans, C. (2003). Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem. J. 372, 173-181.
74. Stacey, M. M., Vissers, M. C., and Winterbourn, C. C. (2012). Oxidation of 2-cys peroxiredoxins in human endothelial cells by hydrogen peroxide, hypochlorous acid, and chloramines. Antioxid. Redox Signal. 17, 411-421.
75. Stevens, J. F., and Maier, C. S. (2008). Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 52, 7-25.
76. Stoyanovsky, D., Murphy, T., Anno, P. R., Kim, Y. M., and Salama, G. (1997). Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21, 19-29.
77. Straus, D. S., and Glass, C. K. (2001). Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21, 185-210.
78. Sun, J., Yamaguchi, N., Xu, L., Eu, J. P., Stamler, J. S., and Meissner, G. (2008). Regulation of the cardiac muscle ryanodine receptor by O(2) tension and S-nitrosoglutathione. Biochemistry 47, 13985-13990.
79. Terentyev, D., Gyorke, I., Belevych, A. E., Terentyeva, R., Sridhar, A., Nishijima, Y., de Blanco, E. C., Khanna, S., Sen, C. K., Cardounel, A. J., Carnes, C. A., and Gyorke, S. (2008). Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure. Circ. Res. 103, 1466-1472.
80. Thannickal, V. J., and Fanburg, B. L. (2000). Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L1005-L1028.
81. Toledo, J. C. Jr., and Augusto, O. (2012). Connecting the chemical and biological properties of nitric oxide. Chem. Res. Toxicol. 25, 975-989.
82. Tu, B. P., and Weissman, J. S. (2004). Oxidative protein folding in eukaryotes:mechanismsandconsequences. J. Cell Biol. 164, 341-346.
83. Uchida, K., and Shibata, T. (2008). 15Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses. Chem. Res. Toxicol. 21, 138-144.
84. Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M. I., Kobayashi, A., Yamamoto, M., Kensler, T. W., and Talalay, P. (2004). Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. U.S.A. 101, 2040-2045.
85. Weiss, S. J., Test, S. T., Eckmann, C. M., Roos, D., and Regiani, S. (1986). Brominating oxidants generated by human eosinophils. Science 234, 200-203.
86. Winterbourn, C. C. (2008). Reconciling the chemistry and biology of reactive oxygen species. Nat. Chem. Biol. 4, 278-286.
87. Winterbourn, C. C., and Hampton, M. B. (2008). Thiol chemistry and specificity in redox signaling. Free Radic. Biol. Med. 45, 549-561.
88. Wu, K. K.,and Liou, J.Y. (2005). Cellular and molecular biology of prostacyclin synthase. Biochem. Biophys. Res. Commun. 338, 45-52
89. Xu, L., Eu, J. P., Meissner, G., and Stamler, J. S. (1998). Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279, 234-237.
90. Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J., Motohashi, H.,andYamamoto, M. (2008). Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol. Cell. Biol. 28, 2758-2770.
91. Yano, M., Okuda, S., Oda, T., Tokuhisa, T., Tateishi, H., Mochizuki, M., Noma, T., Doi, M., Kobayashi, S., Yamamoto, T., Ikeda, Y., Ohkusa, T., Ikemoto, N., and Matsuzaki, M. (2005). Correction of defective interdomain interaction within ryanodine receptor by antioxidant is a new therapeutic strategy against heart failure. Circulation 112, 3633-3643.
92. Zhang, Y., and Hogg, N. (2005). S-Nitrosothiols: cellular formation and transport. Free Radic. Biol. Med. 38, 831-838.
93. Zhao, L., Lee, J. Y., and Hwang, D. H. (2011). Inhibition of pattern recognition receptormediated inflammation by bioactive phytochemicals. Nutr. Rev. 69, 310-320.
94. Zou, M. H. (2007). Peroxynitrite and protein tyrosine nitration of prostacyclin synthase. Prostaglandins Other Lipid Mediat. 82, 119-127.
95. Zou, M. H., Leist, M., and Ullrich, V. (1999). Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am. J. Pathol. 154, 1359-1365.